liraglutide sublingual
/ BioLingus
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 06, 2025
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
(clinicaltrials.gov)
- P1/2 | N=15 | Recruiting | Sponsor: Biolingus | Trial completion date: Jul 2024 ➔ Mar 2026 | Trial primary completion date: May 2024 ➔ Dec 2025
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
July 31, 2023
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
(clinicaltrials.gov)
- P1/2 | N=15 | Recruiting | Sponsor: Biolingus | Not yet recruiting ➔ Recruiting | Trial completion date: Sep 2023 ➔ Jul 2024 | Trial primary completion date: Jul 2023 ➔ May 2024
Enrollment open • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1